"Global Veterinary Oncology Market Overview:
Global Veterinary Oncology Market is expected to grow at a significant rate during the forecast period 2025-2032, with 2024 as the base year.
Global Veterinary Oncology Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Veterinary Oncology involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Veterinary Oncology Market:
The Veterinary Oncology Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Veterinary Oncology Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Veterinary Oncology Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Veterinary Oncology market has been segmented into:
Companion Animal (Equine
Canine
and Feline
By Application, Veterinary Oncology market has been segmented into:
Chemotherapy
Combination Therapy
Immunotherapy
and Targeted Therapy
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Veterinary Oncology market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Veterinary Oncology market.
Top Key Players Covered in Veterinary Oncology market are:
Zoetis Inc.
Elanco
AB Science
Boehringer Ingelheim International GmbH
Zenoaq
VetDC
Morphogenesis
Inc.
Karyopharm Therapeutics
Inc.
Regeneus Ltd.
AdvaVet
Inc.
Rhizen Pharmaceutical SA.
PetCure Oncology
Varian Medical Systems
Accuray Incorporated
Merck Animal Health
Regeneus Ltd.
VolitionRx Limited
"
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Veterinary Oncology Market by Type
4.1 Veterinary Oncology Market Snapshot and Growth Engine
4.2 Veterinary Oncology Market Overview
4.3 Companion Animal (Equine
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Companion Animal (Equine: Geographic Segmentation Analysis
4.4 Canine
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Canine: Geographic Segmentation Analysis
4.5 and Feline
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 and Feline: Geographic Segmentation Analysis
Chapter 5: Veterinary Oncology Market by Application
5.1 Veterinary Oncology Market Snapshot and Growth Engine
5.2 Veterinary Oncology Market Overview
5.3 Chemotherapy
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Chemotherapy: Geographic Segmentation Analysis
5.4 Combination Therapy
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Combination Therapy: Geographic Segmentation Analysis
5.5 Immunotherapy
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Immunotherapy: Geographic Segmentation Analysis
5.6 and Targeted Therapy
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 and Targeted Therapy: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Veterinary Oncology Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 ZOETIS INC.
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 ELANCO
6.4 AB SCIENCE
6.5 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
6.6 ZENOAQ
6.7 VETDC
6.8 MORPHOGENESIS
6.9 INC.
6.10 KARYOPHARM THERAPEUTICS
6.11 INC.
6.12 REGENEUS LTD.
6.13 ADVAVET
6.14 INC.
6.15 RHIZEN PHARMACEUTICAL SA.
6.16 PETCURE ONCOLOGY
6.17 VARIAN MEDICAL SYSTEMS
6.18 ACCURAY INCORPORATED
6.19 MERCK ANIMAL HEALTH
6.20 REGENEUS LTD.
6.21 AND VOLITIONRX LIMITED
Chapter 7: Global Veterinary Oncology Market By Region
7.1 Overview
7.2. North America Veterinary Oncology Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Companion Animal (Equine
7.2.4.2 Canine
7.2.4.3 and Feline
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Chemotherapy
7.2.5.2 Combination Therapy
7.2.5.3 Immunotherapy
7.2.5.4 and Targeted Therapy
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Veterinary Oncology Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Companion Animal (Equine
7.3.4.2 Canine
7.3.4.3 and Feline
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Chemotherapy
7.3.5.2 Combination Therapy
7.3.5.3 Immunotherapy
7.3.5.4 and Targeted Therapy
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Veterinary Oncology Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Companion Animal (Equine
7.4.4.2 Canine
7.4.4.3 and Feline
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Chemotherapy
7.4.5.2 Combination Therapy
7.4.5.3 Immunotherapy
7.4.5.4 and Targeted Therapy
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Veterinary Oncology Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Companion Animal (Equine
7.5.4.2 Canine
7.5.4.3 and Feline
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Chemotherapy
7.5.5.2 Combination Therapy
7.5.5.3 Immunotherapy
7.5.5.4 and Targeted Therapy
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Veterinary Oncology Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Companion Animal (Equine
7.6.4.2 Canine
7.6.4.3 and Feline
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Chemotherapy
7.6.5.2 Combination Therapy
7.6.5.3 Immunotherapy
7.6.5.4 and Targeted Therapy
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Veterinary Oncology Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Companion Animal (Equine
7.7.4.2 Canine
7.7.4.3 and Feline
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Chemotherapy
7.7.5.2 Combination Therapy
7.7.5.3 Immunotherapy
7.7.5.4 and Targeted Therapy
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Veterinary Oncology Scope:
|
Report Data
|
Veterinary Oncology Market
|
|
Veterinary Oncology Market Size in 2025
|
USD XX million
|
|
Veterinary Oncology CAGR 2025 - 2032
|
XX%
|
|
Veterinary Oncology Base Year
|
2024
|
|
Veterinary Oncology Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Zoetis Inc., Elanco, AB Science, Boehringer Ingelheim International GmbH, Zenoaq, VetDC, Morphogenesis, Inc., Karyopharm Therapeutics, Inc., Regeneus Ltd., AdvaVet, Inc., Rhizen Pharmaceutical SA., PetCure Oncology, Varian Medical Systems, Accuray Incorporated, Merck Animal Health, Regeneus Ltd., and VolitionRx Limited.
|
|
Key Segments
|
By Type
Companion Animal (Equine
Canine
and Feline
By Applications
Chemotherapy
Combination Therapy
Immunotherapy
and Targeted Therapy
|
